Tema Neuroscience and Mental Health ETF (MNTL)

Assets	$10.31M
Expense Ratio	0.75%
PE Ratio	21.94
Shares Out	440,000
Dividend (ttm)	$0.26
Dividend Yield	1.10%
Ex-Dividend Date	Dec 11, 2024
Payout Ratio	25.23%
1-Year Return	-14.50%

Volume	116
Open	22.68
Previous Close	23.09
Day's Range	22.35 - 22.68
52-Week Low	22.35
52-Week High	27.66
Beta	n/a
Holdings	48
Inception Date	Jan 22, 2024

About MNTL

Fund Home Page

The Tema Neuroscience and Mental Health ETF (MNTL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, concentrating on companies engaged in addressing disorders of the central nervous system and mental health worldwide. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. MNTL was launched on Jan 22, 2024 and is issued by Tema.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NASDAQ
• Ticker Symbol: MNTL
• ETF Provider: Tema

Top 10 Holdings

52.61% of assets

Name	Symbol	Weight
Vertex Pharmaceuticals Incorporated	VRTX	10.98%
Regeneron Pharmaceuticals, Inc.	REGN	7.94%
Alnylam Pharmaceuticals, Inc.	ALNY	5.16%
argenx SE	ARGX	5.08%
Crinetics Pharmaceuticals, Inc.	CRNX	4.40%
Eli Lilly and Company	LLY	4.36%
Neurocrine Biosciences, Inc.	NBIX	4.28%
Teva Pharmaceutical Industries Limited	TEVA	4.22%
Biogen Inc.	BIIB	3.36%
Stryker Corporation	SYK	2.82%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 11, 2024	$0.25697	Dec 12, 2024